Post Tagged with: "pure-bioscience"

PURE(R) Hard Surface Disinfectant Remediates Listeria Contamination in Shuttered Food Processing Facility

White Paper Documents Successful Use of PURE–s SDC Antimicrobial in Closed Processing Plant — Equipment and Plant Now Deemed Safe for Production by FDA

Read more ›
PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014

PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014

SAN DIEGO, CA — (Marketwired) — 12/02/14 — (OTCQB: PURE), creator of the patented silver dihydrogen citrate () antimicrobial, today announced that the Company will host an investor conference call on Thursday, December 11, 2014 at 1:30pm PST (4:30pm EST).Along with fiscal first quarter financial results, PURE–s management will review:The progress update of its ongoing sales efforts for PURE® Hard Surface disinfectant into SUBWAY® Restaurants*, other restaurants and food processor/m

Read more ›
PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With SUBWAY(R) Restaurants and Others

PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With SUBWAY(R) Restaurants and Others

SAN DIEGO, CA — (Marketwired) — 11/12/14 — PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate () antimicrobial, today provided an update on its sales path to commercialize as a superior disinfectant for food contact surfaces in restaurant chains and food processors/manufacturers.Despite the recently announced delay in the FDA approval process to commercialize SDC as a direct food contact poultry processing aid, PURE remains laser focused on its core, prim

Read more ›
PURE Bioscience Hosts Year-End Results Conference Call October 28, 2014 to Review Progress of SDC Antimicrobial-Based Food Safety Solutions Strategy

PURE Bioscience Hosts Year-End Results Conference Call October 28, 2014 to Review Progress of SDC Antimicrobial-Based Food Safety Solutions Strategy

SAN DIEGO, CA — (Marketwired) — 10/20/14 — (OTCQB: PURE), creator of the patented silver dihydrogen citrate () antimicrobial, today announced that the Company will host an investor conference call on Tuesday, October 28, 2014 at 1:30pm PDT (4:30pm EDT).In addition to discussion of fiscal year end 2014 results, the will review the latest progress made in commercializing SDC as a food safety solution:Quick Service Restaurants (QSRs) StatusCompleted 650 store SUBWAY® Restaurants market tes

Read more ›
PURE Hard Surface Disinfectant Now Available for Use in Subway(R) Restaurants Nationwide

PURE Hard Surface Disinfectant Now Available for Use in Subway(R) Restaurants Nationwide

New Generation of Effective, Eco-Friendly Pathogen Control

Read more ›
PURE Bioscience Reports Fiscal First Quarter 2014 Financial Results

PURE Bioscience Reports Fiscal First Quarter 2014 Financial Results

Early Progress on Food Safety Solutions Strategy, Improved Financial Condition

Read more ›
PURE Announces Strategic Collaboration With Intercon Chemical Company

PURE Announces Strategic Collaboration With Intercon Chemical Company

Manufacturing and Supply Chain Outsourced and Distribution Agreement Established

Read more ›
PURE Announces Distribution Agreement With Brenntag Specialties, Inc.

PURE Announces Distribution Agreement With Brenntag Specialties, Inc.

Global Distribution Rights of SILVERION(R) 2400 for Personal Care Products

Read more ›
PURE Bioscience to Present at 6th Annual LD MICRO Conference

PURE Bioscience to Present at 6th Annual LD MICRO Conference

SAN DIEGO, CA — (Marketwired) — 11/25/13 — (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Peter C. Wulff, CFO & COO, will present at the Sixth Annual LD MICRO Conference on Thursday, December 5th, at 1:00 PST, at the Luxe Hotel Sunset Boulevard in Los Angeles.Mr. Wulff will discuss the Company-s outlook and the progress of the efforts of the new management team to establish PURE-s SDC technology as a novel and proprietary food s

Read more ›
PURE Bioscience Reports Fiscal 2013 Year End Financial Results

PURE Bioscience Reports Fiscal 2013 Year End Financial Results

New Management Team Refocusing Strategy, Restoring Financial Condition

Read more ›